The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
Open accessAbstract
Background Neurofibrillary pathology has a stereotypical progression in Alzheimer's disease (AD) that is encapsulated in the Braak staging scheme; however, some AD cases are atypical and do not fit into this scheme. We aimed to compare clinical and neuropathological features between typical and atypical AD cases.Methods AD cases with a Braak neurofibrillary tangle stage of more than IV were identified from a brain bank database. By use of thioflavin-S fluorescence microscopy, we assessed the density and the distribution of neurofibrillary tangles in three cortical regions and two hippocampal sectors. These data were used to construct an algorithm to classify AD cases into typical, hippocampal sparing, or limbic predominant. Classified cases were then compared for clinical, demographic, pathological, and genetic characteristics. An independent cohort of AD cases was assessed to validate findings from the initial cohort.Findings 889 cases of AD, 398 men and 491 women with age at death of 37-103 years, were classified with the algorithm as hippocampal sparing (97 cases [11%]), typical (665 [75%]), or limbic predominant (127 [14%]). By comparison with typical AD, neurofibrillary tangle counts per 0.125 mm(2) in hippocampal sparing cases were higher in cortical areas (median 13, IQR 11-16) and lower in the hippocampus (7.5, 5.2-9.5), whereas counts in limbic-predominant cases were lower in cortical areas (4.3, 3.0-5.7) and higher in the hippocampus (27, 22-35). Hippocampal sparing cases had less hippocampal atrophy than did typical and limbic-predominant cases. Patients with hippocampal sparing AD were younger at death (mean 72 years [SD 10]) and a higher proportion of them were men (61 [63%]), whereas those with limbic-predominant AD were older (mean 86 years [SD 6]) and a higher proportion of them were women (87 [69%]). Microtubule-associated protein tau (MAPT) H1H1 genotype was more common in limbic-predominant AD (54 [70%]) than in hippocampal sparing AD (24 [46%]; p=0.011), but did not differ significantly between limbic-predominant and typical AD (204 [59%]; p=0.11). Apolipoprotein E (APOE) ɛ4 allele status differed between AD subtypes only when data were stratified by age at onset. Clinical presentation, age at onset, disease duration, and rate of cognitive decline differed between the AD subtypes. These findings were confirmed in a validation cohort of 113 patients with AD.Interpretation These data support the hypothesis that AD has distinct clinicopathological subtypes. Hippocampal sparing and limbic-predominant AD subtypes might account for about 25% of cases, and hence should be considered when designing clinical, genetic, biomarker, and treatment studies in patients with AD.Funding US National Institutes of Health via Mayo Alzheimer's Disease Research Center, Mayo Clinic Study on Aging, Florida Alzheimer's Disease Research Center, and Einstein Aging Study; and State of Florida Alzheimer's Disease Initiative.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“clinical features lack specificity for a pathologic process, but rather indicate brain regions or systems affected by the disease process [3, 4].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Three major subtypes of AD can be classified by the relative density of hippocampal neurofibrillary tangles with respect to neocortical tangles [3].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Genetic analyses of APOE suggest APOE4 is more closely linked to typical or limbic predominant than hippocampal sparing AD [3].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Nonamnestic clinical presentations, that is, language, visuospatial, and executive disorders, may also be due to AD [63–66].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [65]
In the citing paper
“Another challenge of CPC studies is that the molecular, anatomic, and clinical changes of AD may not progress in a uniform fashion (7, 12-15).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
In the citing paper
“and that not all AD cases fall within the same spatial continuum with regard to brain NFT distributions (12, 15, 151).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
In the citing paper
“Nevertheless, Braak staging also masks the fact that marked variability in pathologic lesion density across cases exists within a given Braak stage (7, 12)”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
Self-citationAssociation of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Self-citationBarker, W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 714
Self-citation
Cited by
Sorted by citations
Items 701–800 of 971
Riku, Y., Brion, J., Ando, K., Uchihara, T., & Iwasaki, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412088 · Cited by 6
Hanyu, H., Koyama, Y., Horita, H., Aoki, T., Sato, T., Takenoshita, N., Kanetaka, H., Shimizu, S., Hirao, K., & Watanabe, S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215674 · Cited by 4
Mao, C., Hou, B., Li, J., Chu, S., Huang, X., Wang, J., Dong, L., Liu, C., Feng, F., Peng, B., et al. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220905145756 · Cited by 4
Hanyu, H., Koyama, Y., Horita, H., Watanabe, S., Sato, T., Kanetaka, H., Shimizu, S., & Hirao, K. (2023) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14712 · Cited by 4
Choe, Y. S., Kim, R. E. Y., Kim, H. W., Kim, J. Y., Lee, H., Lee, M. K., Lee, M., Kim, K. Y., Kim, S., Kim, J., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230105 · Cited by 4
Zhang, B., Xu, M., Wu, Q. H., Ye, S., Zhang, Y., Li, Z., & Initiative, A. D. N. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1328301 · Cited by 5
Cammann, D., Lu, Y., Rotter, J. I., Wood, A. C., & Chen, J. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1404377 · Cited by 5
Rui, X., Zhao, X. O., Zhang, N., Ding, Y., Seki, C., Ono, M., Higuchi, M., Zhang, M., Chu, Y., Wei, R., et al. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120947 · Cited by 4
Atrophie corticale postérieure
Sarazin, M., Kas, A., Habert, M., Samri, D., Dubois, B., & de Souza, L. C. (2013) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(13)59694-1 · Cited by 4
Jang, J., & Kim, S. (2019) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2019.1.1 · Cited by 4
Gavett, B. E., Fletcher, E. M., Widaman, K. F., Farias, S. T., DeCarli, C. S., & Mungas, D. (2021) · Neuropsychology · doi:10.1037/neu0000761 · Cited by 4
Case Study 1: A 55-Year-Old Woman With Progressive Cognitive, Perceptual, and Motor Impairments
McGinnis, S. M., Stern, A. M., Woods, J. K., Torre, M., Feany, M. Β., Miller, M. B., Silbersweig, D., Gale, S. A., & Daffner, K. R. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.21040114 · Cited by 4
Carlos, A. F., Koga, S., Graff‐Radford, N. R., Baker, M., Rademakers, R., Ross, O. A., Dickson, D. W., & Josephs, K. A. (2023) · Neuropathology · doi:10.1111/neup.12938 · Cited by 4
Self-citationMultimodal neuroimaging provides insights into the biology of Alzheimer's disease.
Whitwell, J. L. (2018) · Brain : a journal of neurology · doi:10.1093/brain/awy001 · Cited by 4
Jellinger, K. A. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000480 · Cited by 4
Ingrassia, L., Boluda, S., Jiménez, G., Kar, A., Racoceanu, D., Delatour, B., & Stimmer, L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.31.564976 · Cited by 4
Na, H. K., Shin, J., Kim, S.-W., Seo, S., Kim, W., Kang, J. M., Lee, S., Cho, J., Byun, J., Okamura, N., et al. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0308 · Cited by 3
Alanko, V., Mravinacová, S., Hall, A., Hagman, G., Mohanty, R., Westman, E., Nilsson, P., Kivipelto, M., Månberg, A., & Matton, A. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf078 · Cited by 3
Torok, J., Mezias, C., & Raj, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70092 · Cited by 3
Sreepada, L. P., Brown, C. A., Das, S. R., Yushkevich, P. A., Wolk, D. A., & McMillan, C. T. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.06.003 · Cited by 3
Comparison of visual and analytic methods of Alzheimer's disease pathologic staging
Lopresti, B. J., Cohen, A. D., DelBene, A., Reese, A. C., Matan, C., Gogola, A., Chiang, M., Snitz, B. E., Laymon, C. M., Berman, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70520 · Cited by 4
Wang, X.-Y., Jia, Y., Zhang, J., Chen, J., Wang, Y., & Chen, X. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251388664 · Cited by 3
Applications of Endovascular Brain–Computer Interface in Patients with Alzheimer’s Disease
Sun, Y., Chen, D., Ye, Q., You, Z., Zhao, Z., Shi, J., Sun, H., Li, S., Xu, Y., Xu, Y., et al. (2025) · Research · doi:10.34133/research.1049 · Cited by 3
Utilizing multimodal models to forecast Alzheimer's disease progression and clinical subtypes
Ren, H., Jing, F., Zhou, Y., Luo, Z., Yu, X., Jin, W., & Chen, L. (2025) · Health Information Science and Systems · doi:10.1007/s13755-025-00407-w · Cited by 3
Neuropathological correlates of age and sex differences in 18F-flortaucipir PET
Coomans, E. M., Smith, R. A., Pawlik, D., Hauer, K. O., Palmqvist, S., Stomrud, E., Mattsson, N., Tremblay, C., Serrano, G. E., Beach, T. G., et al. (2026) · Brain · doi:10.1093/brain/awag136 · Cited by 3
LATE, Hippocampal Sclerosis, and Primary Age-related Tauopathy
Ramanan, V. K., & Graff‐Radford, J. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001499 · Cited by 4
Exploring Withanolides from Withania somnifera: A Promising Avenue for Alzheimer’s Disease Treatment
Pullaiah, C. P., Preethi Priyadharshini, S. P., Phareedha, S. K., Yamini, N., Birudala, G., Lahari, S., Vippamakula, S., Shakila, R., Ganjayi, M. S., & Raghavendra, M. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00394-2 · Cited by 4
Shang, T., Yang, S., Zhai, T., He, W., Mamourian, E., Zhang, J., Hou, B., Lee, J., Duong-Tran, D. A., Moore, J. H., et al. (2025) · Innovation in Aging · doi:10.1093/geroni/igaf102 · Cited by 3
Juanes, A. M., Vogels, T., Hertog, S. K.-D., Loos, M., Lütjohann, D., Giera, M. A., & van der Kant, R. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100952 · Cited by 3
Magnetic Resonance Spectroscopy in Dementia
Graff‐Radford, J., & Kantarci, K. (2016) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-33555-1_4 · Cited by 3
He, Z., Tian, S., Erdengasileng, A., Charness, N. H., & Bian, J. (2022) · PubMed Central · doi:10.48550/arxiv.2202.10991 · Cited by 3
Ortner, M., Lanz, K., Goldhardt, O., Müller‐Sarnowski, F., Diehl‐Schmid, J., Förstl, H., Hedderich, D. M., Yakushev, I. Y., Logan, C. A., Weinberger, J.-P., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221187 · Cited by 4
Shang, T., Yang, S., He, W., Zhai, T., Li, D., Hou, B., Chen, T., Moore, J. H., Ritchie, M. D., & Shen, L. (2025) · Europe PMC (PubMed Central) · Cited by 3
Human DDIT4L intron retention contributes to cognitive impairment and amyloid plaque formation
Li, K., Shi, H., Li, Z., You, P., Pan, J., Cai, Y.-C., Li, J.-W., Ma, X.-F., Zhang, S., Diao, L., et al. (2025) · Cell Discovery · doi:10.1038/s41421-024-00759-9 · Cited by 3
Abdi, Z., Yong, K. X. X., Schott, J. M., Gatt, A. P., Révész, T., Crutch, S. J., & Lashley, T. (2025) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70007 · Cited by 5
Timalsina, D. R., Abichandani, L. G., & Ambad, R. S. (2025) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_1786_24 · Cited by 3
Meng, W., Yang, Q., Xu, J., Huang, Y., Wang, C., Song, Q., Song, L., Bian, J., Ma, Q., Ma, A., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106391 · Cited by 3
Corlier, F. W., Moyer, D., Braskie, M. N., Thompson, P. M., Dorothée, G., Potier, M., Sarazin, M., Bottlaender, M., & Lagarde, J. (2018) · International Symposium on Medical Information Processing and Analysis (SIPAIM) · doi:10.1117/12.2511573 · Cited by 3
Wczesne rozpoznawanie choroby Alzheimera
Barczak, A. K. (2018) · Pediatria i Medycyna Rodzinna · Cited by 3
Park, S. W., Kim, S., Park, J. H., Jang, J., & Kim, S. (2020) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2020.19.4.129 · Cited by 3
Vemuri, P., & Murray, M. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00070-4 · Cited by 3
Self-citationCamsari, G. B., Murray, M. E., & Graff‐Radford, N. R. (2016) · Neurologic Clinics · doi:10.1016/j.ncl.2016.04.008 · Cited by 3
Self-citationVisualizing evidence for Alzheimer's disease in deep neural networks trained on structural MRI data
Böhle, M., Eitel, F., Weygandt, M., & Ritter, K. (2019) · Cited by 3
LeSCoD: a new clinical scale for the detection of Lewy body disease in neurocognitive disorders
Olivieri, P., Lebouvier, T., Hardouin, J.-B., Courtemanche, H., Dily, S. L., Barbin, L., Pallardy, A., Derkinderen, P., & Boutoleau‐Bretonnière, C. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10539-0 · Cited by 3
Knell, S., Thal, D. R., & Lipp, V. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999370 · Cited by 2
How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?
Donato, L., Mordà, D., Scimone, C., Alibrandi, S., D’Angelo, R., & Sidoti, A. (2023) · Biomedicines · doi:10.3390/biomedicines11072035 · Cited by 3
Vemuri, P., Jack, C. R., & Murray, M. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00014-3 · Cited by 3
Self-citationSun, N., Mormino, E. C., Chen, J., Sabuncu, M. R., Yeo, B. T. T., & Initiative, A. D. N. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462143 · Cited by 3
Predicting future regional tau accumulation in asymptomatic and early Alzheimer’s diseasePreprint
Giorgio, J., Jagust, W. J., Baker, S. L., Landau, S. M., Peter Tiňo, B., Kourtzi, Z., & Initiative, A. D. N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.21203/rs.3.rs-60371/v1 · Cited by 3
Patterns of neurodegeneration in dementia reflect a global functional state spacePreprint
Jones, D. T., Lowe, V. J., Graff-Radford, J., Botha, H., Wiepert, D. A., Murphy, M. C., Murray, M. E., Senjem, M. L., Gunter, J. L., Wiste, H. J., et al. (2020) · medRxiv · doi:10.1101/2020.11.09.20228676 · Cited by 3
Self-citationCrist, A. M., Hinkle, K. M., Wang, X., Moloney, C. M., Matchett, B. J., Labuzan, S. A., Frankenhauser, I., Azu, N. O., Liesinger, A. M., Lesser, E. R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.18.423469 · Cited by 3
Self-citationPoulakis, K., Pereira, J. B., Muehlboeck, J., Wahlund, L., Smedby, Ö., Volpe, G., Masters, C. L., Ames, D. J., Niimi, Y., Iwatsubo, T., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3797614 · Cited by 3
Alzheimer’s disease biomarker profiling in a memory clinic cohort without common comorbiditiesPreprint
Daniilidou, M., Eroli, F., Alanko, V., Goikolea, J., Latorre‐Leal, M., Rodriguez‐Rodriguez, P., Griffiths, W. J., Wang, Y., Pacciarini, M., Brinkmalm, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.09.495140 · Cited by 3
Dadu, A., Ta, M., Tustison, N., Daneshmand, A., Marek, K., Singleton, A. B., Campbell, R. H., Nalls, M., Iwaki, H., Avants, B., et al. (2024) · medRxiv · doi:10.1101/2024.10.27.24316215 · Cited by 4
Kang, J. M., Shin, J., Kim, W., Seo, S., Seo, H., Lee, S.-Y., Park, K. H., Na, D. L., Okamura, N., Seong, J.-K., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230339 · Cited by 2
Ayasse, N. D., Stewart, W. F., Lipton, R. B., Gómez‐Ulloa, D., & Runken, M. C. (2024) · Current Alzheimer Research · doi:10.2174/0115672050316936240905064215 · Cited by 2
How reproducible are data-driven subtypes of Alzheimer's disease atrophy?
Prevot, E., Shand, C., Initiative, A. D. N., & Oxtoby, N. P. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251415019 · Cited by 4
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer’s disease
Venkatraghavan, V., Archetti, D., Bourgeat, P., Jiang, C., ten Kate, M., van Loenhoud, A. C., Ossenkoppele, R., Teunissen, C. E., van de Giessen, E., Pijnenburg, Y. A. L., et al. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121381 · Cited by 2
Vilor‐Tejedor, N., Rodrigo, A., Genius, P., Rodríguez‐Fernández, B., Anastasi, F., Pelkmans, W., Navarro, A., Adams, H. H. H., Wisse, L. E. M., Gispert, J. D., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103889 · Cited by 3
Sekiya, H., Franke, L., Ono, D., Deture, M. A., Ross, O. A., Day, G. S., Lachner, C., Graff‐Radford, N. R., McLean, P. J., Ferman, T. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70904 · Cited by 2
Self-citationNovel Aggressive Subtype of Multiple System Atrophy Identified by Unsupervised Machine Learning
Sekiya, H., Ono, D., Maier, A. R., Soto‐Beasley, A. I., Deture, M. A., Ross, O. A., Uitti, R. J., Cheshire, W. P., Wszołek, Z. K., & Dickson, D. W. (2026) · Annals of Neurology · doi:10.1002/ana.78131 · Cited by 1
Self-citationZilioli, A., Mohanty, R., Rosenberg, A., Matton, A., Granberg, T., Hagman, G., Spallazzi, M., Ferreira, D., Kivipelto, M., & Westman, E. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-01972-2 · Cited by 2
Research progress in neuroimaging of sporadic early-onset Alzheimer’s disease
Zhang, X., & Yang, C. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1788814 · Cited by 2
Lin, M., Chiotis, K., Maiti, P., Zhang, J., Blazhenets, G., Rocha, S., Shankar, R. P., Amuiri, A. N., Hammers, D. B., Eloyan, A., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag176 · Cited by 2
Self-citationRichardson, T. E., Cherry, J. D., Kandoi, S., Rohde, S. K., Uretsky, M., Tuz‐Zahra, F., Bieniek, K. F., Farrell, K. W., Hefti, M. M., Miller, M. B., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03031-4 · Cited by 3
Self-citationDeep learning based decomposition of brain networks
Lee, P., Choi, M., Kim, D., Lee, S., Jeong, H., & Han, C. E. (2019) · International Conference on Artificial Intelligence in Information and Communication (ICAIIC) · doi:10.1109/icaiic.2019.8669055 · Cited by 2
Kameyama, M., Ishibashi, K., Toyohara, J., Wagatsuma, K., Umeda‐Kameyama, Y., Shimoji, K., Kanemaru, K., Murayama, S., Ogawa, S., Tokumaru, A. M., et al. (2020) · Aging · doi:10.18632/aging.104012 · Cited by 2
Deep learning for subtyping the Alzheimer’s disease spectrum
Romano, M. F., & Kolachalama, V. B. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.12.004 · Cited by 2
Fredes-Roa, C., Gutiérrez-Barría, F., Ramírez-Bruna, C., Cigarroa, I., Martella, D., Julio–Ramos, T., Méndez‐Orellana, C., & Toloza–Ramirez, D. (2022) · Neurology Perspectives · doi:10.1016/j.neurop.2022.07.007 · Cited by 2
Small-angle X-ray microdiffraction from fibrils embedded in tissue thin sections
Nepal, P., Bashit, A. A., Yang, L., & Makowski, L. (2022) · Journal of Applied Crystallography · doi:10.1107/s1600576722009955 · Cited by 4
A demenciaellátás innovatív irányai
Dallos, R. G. (2022) · Máltai Tanulmányok · doi:10.56699/mt.2022.4.7 · Cited by 2
Palomo, M. S. M., & Zea‐Sevilla, M. A. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.03.002 · Cited by 4
Gogola, A., Initiative, A. D. N., Cohen, A. D., Snitz, B. E., Minhas, D. S., Tudorascu, D., Ikonomović, M. D., Shaaban, C. E., Doré, V., Matan, C., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240543 · Cited by 2
Multilayer Analysis of RNA Sequencing Data in Alzheimer’s Disease to Unravel Molecular Mysteries
Uzuner, D., İlgün, A., Düz, E., Bozkurt, F. B., & Çakır, T. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69188-1_9 · Cited by 2
Hypometabolic subtypes of AD are linked to comorbid hippocampal sclerosis and Lewy body pathology
Levin, F., Dyrba, M., Teipel, S. J., & Grothe, M. J. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01796-6 · Cited by 2
An, G. Z., Xie, Y., Benzinger, T. L. S., Gordon, B. A., & Sotiras, A. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01850-3 · Cited by 2
Duyckaerts, C. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.007 · Cited by 2
Whittaker, H. T., & Warren, J. D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00076 · Cited by 2
Brain Morphometry: Alzheimer’s Disease
Marco, M. D., & Venneri, A. (2018) · Neuromethods · doi:10.1007/978-1-4939-7647-8_14 · Cited by 2
Cerebral Multimorbidity in Aging
Jellinger, K. A. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2017/1.1001 · Cited by 2
Diagnose It Yourself: Will There Be a Home Test Kit for Alzheimer’s disease?
Menne, F., & Schipke, C. G. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2020-0065 · Cited by 3
Matchett, B. J., Lincoln, S., Baker, M. C., Tamvaka, N., Labuzan, S. A., Sirmans, T. N. H., Moloney, C. M., Helminger, J., Hinkle, K. M., Cabrera-Rodriguez, J. N., et al. (2023) · Medicine · doi:10.1097/md.0000000000034017 · Cited by 2
Self-citationBrain chains as topological signatures for Alzheimer’s disease
Goodbrake, C., Beers, D., Thompson, T., Harrington, H. A., & Goriely, A. (2024) · Journal of Applied and Computational Topology · doi:10.1007/s41468-024-00168-7 · Cited by 2
Stefanovski, L., Meier, J. M., Pai, R. K., Triebkorn, P., Lett, T. A. P., Martin, L., Bülau, K., Hofmann‐Apitius, M., Solodkin, A., McIntosh, A. R., et al. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/4t5qa · Cited by 2
Frigerio, I., Boon, B. D. C., Lin, C.-P., Graaf, Y. G.-D., Bol, J. G. J. M., Preziosa, P., Twisk, J. W. R., Barkhof, F., Hoozemans, J. J. M., Bouwman, F. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.16.448650 · Cited by 2
pySuStaIn: a Python implementation of the Subtype and Stage Inference algorithmPreprint
Aksman, L., Wijeratne, P. A., Oxtoby, N. P., Eshaghi, A., Shand, C., Altmann, A., Alexander, D. C., & Young, A. L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.09.447713 · Cited by 3
Brucki, S. M. D. (2011) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642011dn05040014 · Cited by 2
Gawor, K., Tomé, S. O., Vandenberghe, R. R., Damme, P. V., Vandenbulcke, M., Otto, M., Arnim, C. A. F. V., Ghebremedhin, E., Ronisz, A., Ospitalieri, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.599515 · Cited by 2
Shir, D., Corriveau‐Lecavalier, N., Graff‐Radford, J., Machulda, M. M., Knopman, D. S., Petersen, R. C., Nguyen, A. T., Dickson, D. W., & Jones, D. T. (2024) · Neurocase · doi:10.1080/13554794.2024.2348223 · Cited by 1
Self-citationAmplifying Efficiency and Accuracy in Dementia Drug Development
Lerch, O., Levine, S. Z., Sivakumaran, S., Lutz, M. W., Chiba‐Falek, O., Mazer, N. A., Bairu, M., Haraldsen, I., Rossini, P. M., Snyder, P. J., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.167 · Cited by 1
Biomarkers for Alzheimer's Disease
Panwar, D., Sharma, P., Sharma, S., Malik, M., & Kaur, J. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-6442-0.ch003 · Cited by 1
Zhang, H., Hamit, D., Li, Q., Hu, X., Li, S.-F., Xu, F., Wang, M., Bao, G.-Q., & Li, H. (2025) · Scientific Reports · doi:10.1038/s41598-024-80755-x · Cited by 1
The Psychopathology and Neuropsychology of Alzheimer’s Disease: A New Narrative
Barakat, M., Annan, I., Sader, A., & Khoury, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_54-1 · Cited by 1
Cerebrospinal Fluid Biomarker Profile in Atypical Alzheimer’s Disease
Campos, E. M., Tellechea-Aramburo, P., de Gordoa, J. S., & Ilundáin, R. L. (2025) · Revista de Neurología · doi:10.31083/rn36399 · Cited by 1
Sex and ethnicity in early‐onset Alzheimer's disease biomarkers and global function
Asken, B. M., Wang, W., Arias, F., Levy, S.-A. T., Barker, W., Rosselli, M., Curiel, R. E., Marsiske, M., Armstrong, M. J., Vaillancourt, D. E., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70157 · Cited by 1
Self-citationDifferential MRI atrophy profiles and incident dementia: A cross-national comparison
Walters, M. E., Small, B. J., Andel, R., Lerch, O., Horáková, H., Molinari, V., Salemi, J. L., Vyhnálek, M., Nedelská, Z., Hort, J., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251371734 · Cited by 1
Alkemade, A., Bazin, P., Kirilina, E. P., Pine, K., Herrler, A., Bleijs, R. L. A. W., Kros, J. M., Groenewegen, L., Vermorgen, S., Jonkman, L. E., et al. (2025) · Brain Pathology · doi:10.1111/bpa.70039 · Cited by 1
Christodoulou, R. C., Vamvouras, G., Sarquis, M. D., Petrou, V., Papageorgiou, P. S., Rivera, L., Morales, C., Rivera, G., Vassiliou, E. K., Solomou, E. E., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13112632 · Cited by 1
Licciardo, D., Matti, C., Benelli, A., Isella, Appollonio, I. M., & Santarnecchi, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106554 · Cited by 1
Woffindale, C., Riera, N. G., Wood, M. J. A., & Varela, M. A. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102848 · Cited by 1
Metadata
- Authors
- Murray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R., & Dickson, D. W.
- Affiliations
- Mayo Clinic (US)
- Mount Sinai Medical Center (US)
- Corresponding author
- Dickson, Dennis W
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 10
- Issue
- 9
- Pages
- 785-796
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC3175379
- OpenAlex
- W2075444764
- Cited by
- 972
- References
- 44
- Citations by year
- 2026: 60 · 2025: 80 · 2024: 78 · 2023: 96 · 2022: 80 · 2021: 104 · 2020: 70 · 2019: 73 · 2018: 56 · 2017: 50 · 2016: 55 · 2015: 37 · 2014: 36 · 2013: 54 · 2012: 35
- FWCI
- 29.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- National Institutes of Health
- National Institute on Aging (P50‐AG16574, U01AG06786, P50 AG215711, P01AG03949, U01AG006786, P01AG003949, R21AG038736, P50AG025711, P01AG017216, P50AG016574)
- National Institute of Neurological Disorders and Stroke (P50NS072187)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, Braak staging, hippocampal sparing, hippocampal atrophy, tau pathology, clinical features, atypical Alzheimer's disease, sex differences, age at death, genetic risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Hippocampus, Humans, Limbic System, Male, Middle Aged, Retrospective Studies, Cohort Studies, Neurofibrillary Tangles, tau Proteins, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
